TY - JOUR ID - TI - Intravenous Immunoglobulin Therapy in Postpoliomyelitis Syndrome AU - Saad Kazim Karim PY - 2019 VL - 16 IS - 1 SP - 79 EP - 80 JO - Medical Journal of Babylon مجلة بابل الطبية SN - 1812156X 23126760 AB - Postpoliomyelitis syndrome is a new neurological disorder seen in individuals who survive remote poliomyelitis. An adequate diagnosis is importantfor treatment and prognosis. The diagnosis of postpoliomyelitis syndrome might be difficult as the diagnosis mostly depends on the patient’s subjectivedescription of the symptoms. The diagnostic criteria primarily depend on new and progressive muscle weakness, muscle fatigue, general fatigue, andpain in the absence of other disorders which may be similar to this syndrome. Furthermore, the postpoliomyelitis syndrome patients have reachedan age when concomitant diseases are common. The possible etiology is that this entity of paralysis can be exploited by slowly progressive distalneuronal degeneration. Interestingly, this patient had primary upper limb polio paralysis and then new slowly progressive asymmetrical, muscleweakness in the contralateral lower limb. Few clinical trials using human intravenous immunoglobulin (IVIG) and pyridostigmine gave controversyabout a specific treatment. In this case, we tried an IVIG therapy, but the weakness was progressively worsening and there was more atrophy in themuscle bulk of the affected muscle group. However, supportive treatment is also important to be planned. The aim of this case report is to describethe complexity of the diagnosis and treatment of such cases of the postpoliomyelitis syndrome in comparison to relevant literature.

ER -